AL
HALO icon

Airain Ltd’s Halozyme HALO Stock Holding History

Airain Ltd’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-53,552
Closed -$1.21M – 931
2015
Q2 		$1.21M Buy
+53,552
New +$941K 0.07% 304
2014
Q3 		– Sell
-38,794
Closed -$383K – 855
2014
Q2 		$383K Buy
38,794
+5,512
+17% +$46.8K 0.03% 477
2014
Q1 		$423K Buy
+33,282
New +$494K 0.07% 392

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Airain Ltd's HALO Position: Q3 2015 in Review

Airain Ltd sold out of Halozyme (HALO) in Q3 2015, closing a stake of 53,552 shares — an estimated $1.21M sold.

Airain Ltd first reported a position in HALO in Q1 2014 and held it in 3 quarters. The position peaked at $1.21M in Q2 2015. 175 funds tracked by Wall St. Rank hold HALO as of Q3 2015.

  • Airain Ltd reported no remaining Halozyme position as of Q3 2015 after selling out during the quarter.
  • Airain Ltd sold 53,552 Halozyme shares in Q3 2015, an estimated $1.21M.
  • Airain Ltd first reported a position in Halozyme in Q1 2014 and held it in 3 quarters.
  • Airain Ltd's Halozyme position peaked at $1.21M in Q2 2015.
  • 175 funds tracked by Wall St. Rank held Halozyme as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.